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Available online 26 March 2013Two new tryptophan derivatives, N-sulfonyl-L-tryptophan (tryptorheedei A) (1) and 3-(N-
sulfonylindolyl)-D-lactic acid (tryptorheedei B) (2) together with the known 5-O-β-D-
glucopyranosyl-2-hydroxyphenylacetic acid (3), 1-O-methylglucopyranoside, entadamide A,
homogentisic acid and 3-O-β-D-glucopyranosyl-β-sitosterol, were isolated from the seed kernels
of Entada rheedei (Mimosaceae). Their structures were established using 1D and 2D NMR
spectroscopy, mass spectrometry and by comparison with spectroscopic data reported in the
literature. Compounds 1 and 2 showed no toxicity to TZM and Human PBMC cells. Both
compounds 1 and 2were found to promote early infection events in HIV, likely by inhibiting the
enzyme indolamine 2,3-dioxygenase (IDO) and preventing tryptophan depletion. Inhibition of
IDO acutely in HIV infection inhibits viral replication, but chronic activation of IDO leads to
immune impairment in AIDS. IDO is also the gatekeeper enzyme for kynurenine metabolism, a
pathway involved in serotonin and melatonin biosynthesis and the regulation of glutamate and
dopamine levels in the brain. Therefore inhibition of IDO might explain both the reported
medicinal and neuropsychiatric effects of E. rheedei.





As part of our continuous investigation on Cameroonian
medicinal plants [1], we have conducted a phytochemical study
of the seed kernels of Entada rheedei Spreng (Mimosaceae), also
known as E. rheedii [2], a large woody liana or climber growing
naturally throughout tropical Africa and Southeastern Asia.
Tobaccomade from the seeds of this plant has been reported to
cause vivid dreaming and, for this reason, the plant is
commonly known as African dream herb or snuff box sea
bean (entheology.org). E. rheedei has various medicinal uses,
including treatment of jaundice, diarrhea [3], musculo-skeletal
problems[4] and mumps [5]. Previous phytochemical studies
on the genus Entada revealed the presence of saponins [6,7],: +39 0737402297.
oni).
Y-NC-ND license.thioamides [8–10] and phenylacetic acid derivatives [11,12].
More recently, investigation of the seed kernels of E. rheedei led
to the isolation of oleanane-type saponins, thioamide glycosides
[13], and phenylpropanoid glycosides [14]. In a recent paper
some of us reported the isolation and characterization of two
antiproliferative and antioxidant saponins from the n-butanol
extract of the seed kernels of this plant [15]. In the present
study, we describe the isolation and structure elucidation of
two new tryptophan derivatives, N-sulfonyl-L-tryptophan
(tryptorheedei A) (1) and 3-(N-sulfonylindolyl)-D-lactic
acid (tryptorheedei B) (2), together with the known 5-O-β-
D-glucopyranosyl-2-hydroxyphenylacetic acid (3) (Fig. 1),
1-O-methylglucopyranoside, entadamide A ((E)-N-(2-
hydroxyethyl)-3-(methylthio)acrylamide), homogentisic
acid (2-(2,5-dihydroxyphenyl)acetic acid) and 3-O-β-D-
glucopyranosyl-β-sitosterol. Given the important role of trypto-
phanmetabolism via the enzyme indolamine 2,3-dioxygenase 1
Fig. 1.
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diseases [16,17] and their structural similarities to an existing
IDO inhibitor, 1-methyltryptophan (1-MT), compounds 1 and 2
were assayed onHIV infection and for their toxicity to TZM and
Human PBMC (peripheral blood mononuclear) cells. Both
compounds significantly enhanced HIV infection at concentra-
tions above 40 μM. No significant toxicity of the compounds
was observed on cells at concentrations of 80 μM and below.
Since IDO inhibits HIV-1 replication, the loss of inhibition
suggests that these compounds may be competitive inhibitors
of IDO and have an effect at 5 fold less concentration of existing
inhibitors of IDO (200 μM for 1-MT [18]).2. Experimental
2.1. General experimental procedures
Optical rotations were measured on a PerkinElmer 241 MC
Polarimeter. IR spectra were measured as a film on a KBr pellet
using a FTIR-8400S Shimadzu spectrometer. ESIMSwas carried
out on a Hewlett-Packard HP-1100 series LC–MSD system
while FABMS was recorded on a Joel-JMS-700 mass spectrom-
eter using glycerol as matrix. NMR spectra were recorded in
deuterated solvents (CD3OD, C5D5N) on a Bruker AM-500 and a
VarianMercury Plus 400 spectrometer at 500 or 400 MHz (1H)
and 125 or 100 MHz (13C), respectively. All chemicals shifts (δ)
are given in ppm units with reference to the residual solvent
signal and the coupling constant (J) are in Hz. Column
chromatography was performed using silica gel 60 Merck
(63–200 μm and 32–63 μm). TLC was carried out on precoated
silica gel 60 F254 (Merck) plates developed with EtOAc-
MeOH-H2O (9:1:0.5 or 8:2:1). TLC plates were visualized by
spraying with 50% H2SO4 and heating for 10 min at 110 C.2.2. Plant material
The seeds of E. rheedei were collected in Konda village,
Momo Division, North-West region of Cameroon, in August
2005, and authenticated by Dr. Gaston Achoundong, head of
the National Herbarium of Cameroon. A voucher specimen
(No. 19966/SRI/CAM)was deposited at theNational Herbarium
of Cameroon, Yaoundé.2.3. Extraction and isolation
The dried and powdered seeds kernel (2.5 kg) of E. rheedei
was extracted three times bymacerationwith 95% EtOH at room
temperature for 24 h. The filtrate obtained was evaporated
under reduced pressure to yield a brown residue (315 g). Part of
this extract (300 g) was suspended in water (500 ml) and
successively partitioned between EtOAc and n-BuOH, yielding
19.3 and 105.2 g of extracts after evaporation to dryness,
respectively. Part of the EtOAc extract (17.5 g) was subjected to
silica gel (63–200 μm)column chromatography, using a gradient
of MeOH in EtOAc to give six main fractions (A–F). Fraction E
(EtOAc-MeOH (7–3)) was rechromatographed using silica gel
(32–63 μm) with EtOAc-MeOH-H2O (8–2–1) as eluent to afford
compounds 1 (50 mg) and 2 (10 mg). Fraction D (EtOAc-MeOH
(8–2)) was purified by column chromatography over silica gel
(32–63 μm) using EtOAc-MeOH-H2O (10:2:1) as eluent to yield
compound 3 (11 mg) and 1-O-methylglucopyranoside (50 mg).
Fraction C (EtOAc-MeOH (9–1)) was purified by column
chromatography over silica gel (32–63 μm) using EtOAc-
MeOH-H2O (95–5–2) as eluent to yield entadamide A (25 mg)
and 3-O-β-D-glucopyranosyl-β-sitosterol (150 mg) whereas
fraction B (EtOAc) was rechromatographed using silica gel
(32–63 μm) with hexane-EtOAc (3:7) as eluent to afforded
homogentisic acid (17 mg).
N-sulfonyl-L-tryptophan (tryptorheedei A) (1): brown oil;
[α]20D-12.0 (c 0.7, CH3OH); IR (KBr) υmax 3419, 3208, 1731,
1593 cm−1; 1H NMR and 13C NMR data, see Table 1; ESIMS
m/z 283 [M–H]−, 224[M–CO2–NH2]−.
3-(N-sulfonylindolyl)-D-lactic acid (tryptorheedei B) (2):
brown oil; [α]20D +22 (c 1.7, CH3OH); 1H NMR and 13C NMR
data, see Table 1; ESIMSm/z 284 [M–H]−, 286 [M + H]+, 224
[M + H–CO2–H2O]+, 142 [M–CO2–H2O–SO3H]−.
2.4. Acid hydrolysis of compound 3
A solution of compound 3 (3 mg) in water (1 mL) and 2 N
aqueous CF3COOH (10 mL) was heated at reflux at 100 °C for
2 h. The mixture was then diluted in water (10 mL) and
extracted with EtOAc (3 × 3 mL). The aqueous residue was
concentrated to dryness by adding repeatedly MeOH to
remove acid and analysed by TLC (silica gel) in comparison
with standard sugars by using a mixture of CHCl3–MeOH–
AcOH–H2O (60:32:12:8) as the eluant. The absolute config-
uration of the sugar residue was determined by GC analysis of
its chiral derivative [19].
2.5. Bioassay procedure
TZM-bl cell line was obtained from The NIH AIDS Reagent
Program, USA; LuSIV cells were obtained from J. Clements,
and were maintained as previously described [20]; PE
Annexin V Apoptosis Detection Kit was purchased from BD
Biosciences; Vybrant MTT Cell Proliferation Assay Kit from
Invitrogen; and One-Glo Luciferase Assay System from
Promega.
2.5.1. HIV.RF virus preparation
The chronically infected H9 cell line (H9/HIV.RF) was
maintained in cRPMI medium and used to produce infectious
viral particles. H9/HIV.RF cells were cultured in a T-75 flask to
Table 1
NMR spectroscopic data (400 MHz, CD3OD) for tryptorheedei A (1) and B (2), and L-tryptophan.
Tryptorheedei A (1) Tryptorheedei B (2) L-tryptophan
Position δC, type δH (J in Hz) δC δH (J in Hz) δC
1 174.3 / 181.3 / 174.5
2 56.2, CH 3.84 dd (3.5, 10.6) 73.8 4.20 dd (3.1, 8.8) 56.9
3 28.6, CH2 3.05 dd (10.6, 14.1) 32.4 2.88 dd (8.8, 14.7) 28.9
3.55 dd (3.5, 14.1) 3.36 ddd (1.0, 3.1, 14.7)
2′ 127.5, CH 7.50 s 126.8 7.46 br, s 126.8
3′ 112.0, C / 114.9 / 109.7
4′ 119.8, CH 7.73 d (8.2) 120.2 7.67 br, d (7.9) 119.4
5′ 122.1, CH 7.17 t (8.2) 121.5 7.08 ddd (1.2, 7.2, 7.9) 120.2
6′ 124.2, CH 7.24 t (8.2) 123.4 7.16 ddd (1.3, 7.2, 8.2) 122.9
7′ 115.1, CH 7.94 d (8.2) 114.6 7.87 br, d (8.2) 112.6
8′ 137.5, C / 137.0 / 138.8
9′ 130.1, C / 131.5 / 128.8
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tant was harvested and virus was pelleted at 100,000 g for
2 h. Pelleted virus was re-suspended in iRPMI medium and
stored at −80 °C until use. p24 antigen concentration was
quantified.2.5.2. MTT assay
TZM-bl cells were seeded in a 96-well plate the day before
experiment. After overnight culture, cell culture medium in
the well was removed and replaced with fresh medium
containing various concentrations of compounds 1 and 2.
Cells were cultured overnight and then washed twice with
serum-free medium. For each well, 100 μl of fresh medium
containing MTT reagent was added and the cells were
incubated at 37 °C for 4 h. After adding 100 μl/well of 10%
SDS–HCl solution, the plate was incubated at 37 °C overnight
and optical absorbance was read at 570 nm.2.5.3. Flow cytometer assay
Humanperipheral bloodmononuclear cellswere isolated in
the laboratory by standard Ficoll protocol. Cells then were
treated with various concentrations of compounds 1 and 2
overnight. After washing twice with 1×PBS, cells were stained
with Annexin V kit and analyzed with BD LSRFortessa flow
cytometer.2.5.4. Luciferase assay
TZM-bl cells were seeded in a 96-well plate and cultured
overnight. After washing once with 1×PBS, cells were treated
with various concentrations of compounds 1 and 2 with or
without HIV for 24 h. Luciferase assay then was performed
according to manufacturer's protocol. Briefly, reporter cells
were washed with iRPMI before resuspension in cRPMI at a
density of 4 × 10−6/ml. Cells then were seeded (100 μl/well)
in a 96-well plate and mixed with HIV.RF virus at concentra-
tion of 200 ng/ml of p24. Then, compound 1 or 2 was added
to the wells and the cells were incubated overnight (16 h) at
37 °C. After incubation, One-Glo luciferase assay reagent
(Promega, WI, USA) was added (100 μl/well) and the plate
was incubated at room temperature for 5 min and luciferase
activity was measured on a Fluoroskan Ascent Luminometer
(Vantaa, Finland).3. Results and discussion
The EtOAc soluble portion of the ethanol extract from dried
and powdered seed kernels of E. rheedei was subjected to
multiple chromatographic steps to afford two new tryptophan
derivatives, namely tryptorheedei A (1) and tryptorheedei B (2),
together with 5-O-β-D-glucopyranosyl-2-hydroxyphenylacetic
acid (3) [21], 1-O-methylglucopyranoside [22], entadamide A
[8], homogentisic acid [11,12], and 3-O-β-D-glucopyranosyl-
β-sitosterol [23].
Compound 1 was obtained as brown oil, [α]D-12.0° (c 0.7,
CH3OH). Its IR absorptions indicated the presence of a hydroxyl
group (υmax 3419 cm−1), a carbonyl (1731 cm−1), a double
bond (1593 cm−1) and an amine group (3208 cm−1). The
ESI–MS (negative-ion mode) showed a quasimolecular ion
peak at m/z 283 [M–H]−, consistent with the molecular
formula of C11H12O5N2S, and an intense peak at m/z 224 [M–
CO2–NH2]−. The 1H NMR spectrum of 1 revealed signals for
aromatic protons at δ 7.94 (d, J = 8.2 Hz, H-7′); 7.24 (t, J =
8.2 Hz, H-6′); 7.17 (t, J = 8.2 Hz, H-5′), 7.73 (d, J = 8.2 Hz,
H-4′) and 7.50 (s, H-2′). Signals at δ 3.84 (dd, J = 3.5, 10.6 Hz,
H-2), 3.55 (dd, J = 3.5, 14.1 Hz, H-3a) and 3.05 (dd, J = 10.6,
14.1 Hz, H-3b) suggested that compound 1 is a tryptophan
derivative [24]. The 13C NMR signals of compound 1,
compared to those of tryptophan (Table 1), show a slight
downfield shift in the aromatic region, probably due to the
presence of the sulfonyl group attached to the indolic nitrogen
atom. Assignments of proton and carbon signals of 1 were
achieved by 1H–1H COSY, HSQC andHMBC. The S configuration
of carbon 2 was assigned by comparison of its optical rotation
([α]D = −12.0° (c 0.7, CH3OH) with that of L-tryptophan
([α]D = −55.9° (c 0.3, CH3OH). This stereochemistry of C-2 is
in good agreementwith the fact that naturally occurring amino
acids have the L configuration at their α-carbon atom [25]. The
structure of compound 1 was thus elucidated as N-sulfonyl-
L-tryptophan, a new naturally occurring metabolite to which
we gave the trivial name tryptorheedei A.
Compound 2 was also obtained as brown oil, [α]D + 22°
(c 1.7, CH3OH). It was assigned the molecular formula
C11H11O6NS as determined by the ESI–MS (negative-ion
mode) which showed a quasimolecular ion peak at m/z 284
[M–H]− and an important ion fragment at m/z 142 [M–CO2–
H2O–SO3H]−. This implies that compound 2 has one more
atomic units mass than tryptorheedei A. The 1H and 13C NMR
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superimposable. The 1H NMR spectrum of 2 exhibited signals
at δ 7.87 (brd, J = 8.2 Hz, H-7′); 7.16 (ddd, J = 1.3, 7.2,
8.2 Hz, H-6′); 7.08 (ddd, J = 1.2, 7.2, 7.9 Hz, H-5′), 7.67 (brd,
J = 7.9 Hz, H-4′) amd 7.46 (brs, H-2′), characteristic of
tryptophan derivatives [24,26,27]. The 13C NMR spectrum
showed a downfield shift of C-2 in compound 2 with respect
to compound 1 (73.8 ppm in 2 vs 56.2 ppm in 1), suggesting
the presence of an OH group at C-2 in compound 2 instead of
the NH2 group present in 1. Assignments of proton and
carbon signals of 2 were completed by 1H–1H COSY, HSQC
and HMBC. The R configuration of carbon C-2 was assigned by
comparison of its optical rotation ([α]D + 22° (c 1.7,
CH3OH)) with that of L-tryptophan ([α]D = −55.9° (c 0.3,
CH3OH)). Thus, the structure of 2 was concluded to be
3-(N-sulfonylindolyl)-D-lactic acid, a new derivative to
which we gave the trivial name tryptorheedei B.
Compound 3 was obtained as an amorphous solid. Its
molecular formula was determined as C14H18O9 by the FAB–MS
(negative-ion mode) which showed the quasimolecular ion
peak atm/z 328 [M–2H]−. The 1H NMR spectrum of 3 showed
signals for three aromatic protons at δ 7.03 (d, J = 8.6 Hz, H-3);
7.14 (dd, J = 8.6, 2.6 Hz, H-4) and 7.34 (d, J = 2.6 Hz, H-6).
The two protons singlet for a methylene group observed at δ
3.88 was quite characteristic of phenylacetic acid derivatives
[11,12]. In addition, this spectrum revealed the presence of an
anomeric proton signal at δ 5.32 (d, J = 7.8 Hz, H-1′). In the 13C
NMR spectrum, the characteristic signals of six aromatic
carbons, a methylene group at δ 40.0 ppm, a carboxyl group
at δ 176.8 ppm and an anomeric carbon at δ 102.8 (C-1′)
confirmed that compound 3 was a phenylacetic acid glycoside
(Table 2). The sugar was identified as β-D-glucopyranose by
comparison of its 1H and 13C NMR spectral data (Table 2) with
those of β-anomers of glucopyranose derivatives [22], and
confirmed, after hydrolysis, by chromatographic methods. The
complete assignments 1H and 13C resonances were achieved
by 1H–1H COSY, HSQC and HMBC. In the HMBC spectrum, the
correlation between the anomeric proton δ 5.32 (H-1′) and the
carbon at δ 151.1 (C-5) allowed us to locate the sugar unit at
C-5 of the aglycone rather than placing it at C-2 as found in
phaseoloidin (2-(2-O-β-D-glucopyranosyl-5-hydroxyphenyl)Table 2
NMR spectroscopic data (500 MHz, C5D5N) for compound 3.
Compound 3
position δC, type δH (J in Hz)
1 124.9, C /
2 152.1, C /
3 116.6, CH 7.03 d (8.6)
4 116.3, CH 7.14 dd (8.6, 2.6)
5 151.1, C /
6 120.2, C 7.34 d (2.6)
7 40.0, CH2 3.88 s
8 176.5, C /
1′ 102.8, CH 5.32 d (7.8)
2′ 74.4, CH 4.14 dd (8.9, 7.8)
3′ 77.6, CH 4.28 bt (9.0)
4′ 70.8, CH 4.17 nd
5′ 77.8, CH 3.92 m
6′ 61.9, CH2 4.20 dd (12.0, 5.0), 4.38 dd (12.0, 2.4)acetic acid)), commonly isolated from related species [6,11].
Thus, compound 3was elucidated as 5-O-β-D-glucopyranosyl-
2-hydroxyphenylacetic acid, a glycoside of homogentisic acid. As
far as we know the same structure was reported once in the
literature, but its identification was only based on chemical
transformations, and spectroscopic data were not reported [21].
The structures of the known 1-O-methylglucopyranoside,
entadamide A, homogentisic acid and 3-O-β-D-glucopyranosyl-
β-sitosterol were confirmed by comparison with data reported
in the literature.
Thioamides named entadamides A–C and entadamide
A-β-D-glucopyranoside were previously isolated from Entada
phaseoloides [8–11]. The phenylacetic acid derivative named
phaseoloidin was isolated in a very large amount from the
seed kernels of E. phaseoloides [11] and Entada pursaetha [6]
and seems to be the chemotaxonomic marker of this genus.
Although during our investigation we have not isolated
phaseoloidin but the isomer 5-O-β-D-glucopyranosyl-2-
hydroxyphenylacetic acid (3), its presence, together with
the isolation of entadamide A, shows the chemical homoge-
neity, in terms of metabolite profile, of plant species
belonging to the genus Entada. Furthermore, amino-acid
derivatives such as dopamine 3-O-glucopyranoside and
tyrosine O-glucopyranoside were isolated from E. pursaetha
[28].
Large molecular weight polyanionic compounds such as
dextran sulfate and suramin have previously been reported
to be inhibitors of the HIV-1 integrase enzyme in vitro [29]. A
series of smaller molecular weight mono, and di-sulfonated
compounds with comparable potency was identified [30].
Furthermore, tryptophan is one of the essential amino acids
implicated in the immune system defense [31,32]. Polyanions
are also reported to interfere with the fusion process through
charge-based interactions with the V3 loop of gp120 [33]. It
was therefore quite obvious to assay the two sulfonated
indoles on HIV infection. To this end we tested the effects of
compounds 1 and 2 on HIV-1 infection using two different
reporter cell lines, TZM-bl cells and LuSIV cells. TZM-bl cells
are derived from HeLa cells, whereas LuSIV cells are derived
from a B/T cell hybrid line that is routinely used to produce
virus [34]. Although both lines showed a positive effect of
compound 2, TZM-bl cells showed higher variability, thus we
repeated our experiments using LuSIV cells, a more biolog-
ically relevant cell line in sixplicate. Both compounds 1 and 2
enhanced HIV-1 infection at concentrations of 40 and 80 μM
(Fig. 2C). Experimental results were confirmed with three
independent experiments. The compounds appeared to have
minimal toxicity on both reporter cells and isolated periph-
eral blood mononuclear cells (PBMCs) at concentrations less
than 40 μM (Fig. 2A and B), thus we believe the effect of
compounds to be specific rather than due to toxicity. While
the minimum effective concentration of compounds 1 and 2
are in the μM range, the effective concentration of 1-MT, the
existing inhibitors of IDO is in the range of 200 μM [18].
Given the position of the sulfate group is in the active site
of IDO [35], we posit that both compounds 1 and 2 are acting
as competitive inhibitors of IDO in a mechanism similar to
that observed for 1-MT, a drug being used in cancer therapy
to prevent tumor associated suppression of the immune
response [36]. Similar uses of 1-MT have been proposed for
the treatment of patients with AIDS; however, preliminary
Fig. 2.
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pancreatitis [37]. Thus these compounds may offer an
alternative as potential therapeutic for cancer and AIDS.
While our results may seem paradoxical as the compounds
increase HIV-1 replication, the acute induction of IDO is
beneficial as it prevents T cell activation required for HIV-1
replication. Whereas the same inhibition of T cell responses
by IDO in chronic HIV-1 infection leads to immune impair-
ment and AIDS [16].
IDO in addition to its immune regulatory functions is also
the gatekeeper for kynurenine metabolism, which is a central
metabolic pathway in the CNS and implicated in several
neurological diseases [17]. Also kynurenic acid, a metabolite
of the pathway has been shown to modulate extracellular
dopamine and glutamate levels [17]. Tryptophan is also the
precursor for both serotonin and melatonin [17]. If trypto-
phan is diverted to kynurenine metabolites, it would be
unavailable for synthesis of serotonin and melatonin. We
think that the observed effects of vivid dreaming and
hallucinations offer more indirect support for the involve-
ment of compounds 1 and 2 on IDO activity, and might shed
light on the folklore associated with E. rheedei.
Acknowledgments
This research was supported by the International Foun-
dation for Science (IFS, Stockholm, Sweden) through a grant
to Prof. Tapondjou A. Léon (RGA No. F/3976-2). The authorswould also like to thank MIUR for supporting this research
through the COOPERLINK 2011 Prot. CII113PPUC “Tesi di
Dottorato sullo studio di molecole biologicamente attive
estratte da piante della medicina tradizionale del Camerun”.
Conflict of interest
The authors declare no conflict of interest.Appendix A. Supplementary data
1H and 13C NMR spectra for compounds 1–3 can be found
online at http://dx.doi.org/10.1016/j.fitote.2013.03.017.References
[1] Tapondjou LA, Nyaa LBT, Tane P, Ricciutelli M, Quassinti L, Bramucci M,
et al. Cytotoxic and antioxidant triterpene saponins from Butyrospermum
parkii (Sapotaceae). Carbohydr Res 2011;346:2699–704.
[2] The International Plant Names Index. Published on the Internet http://
www.ipni.org; 2008. [accessed 25 June 2012].
[3] Dash SK, Padhy S. Review on ethnomedicines for diarrhoea diseases
from Orissa: prevalence versus culture. J Hum Ecol 2006;20:59–64.
[4] Uprety Y, Asselin H, Boon EK, Yadav S, Shrestha KKJ. Indigenous uses
and bio-efficacy of medicinal plants in Rasuwa district, Central Nepal.
Ethnobiol Ethnomed 2010;6:3.
[5] Shivanna MB, Rajakumar N. Traditional medico-botanical knowledge of
local communities in Hosanagara Taluk of Shimoga District in Karnataka,
India. J Herbs Spices Med Plants 2001;17:291–317.
[6] Tapondjou AL, Miyamoto T, Mirjolet J-F, Guilbaud N, Lacaille-Dubois M-A.
Pursaethosides A–E, triterpene saponins from Entada pursaetha. J Nat Prod
2005;68:1185–90.
42 L.K. Nzowa et al. / Fitoterapia 87 (2013) 37–42[7] Cioffi G, Dal PF, De Caprariis P, Sanego R, Marzocco S, Autore G, et al.
Antiproliferative triterpene saponins from Entada africana. J Nat Prod
2006;69:1323–9.
[8] Ikegami F, Shibasaki I, Ohmiya S, Ruangrungsi N,Murakoshi I. Entadamide
A, a new sulphur-containing amide from Entada phaseoloides seeds. Chem
Pharm Bull 1985;33:5153–4.
[9] Ikegami F, Ohmiya S, Ruangrungsi N, Sakai S-I, Murakoshi I. Entadamide
B, a second new sulphur-containing amide from Entada phaseoloides.
Phytochemistry 1987;26:1525–6.
[10] Ikegami F, Sekine T, Duangteraprecha S, Matsushita N, Matsuda N,
Ruangrungsi N, et al. Entadamide C, a sulphur-containing amid from
Entada phaseoloides. Phytochemistry 1989;28:881–2.
[11] Barua AK, Chakrabarty M, Datta PK, Ray S. Phaseoloidin, a homogentisic
acid glucoside from Entada phaseoloides. Phytochemistry 1988;27:
3259–61.
[12] Dai J, Kardono LBS, Tsauri S, Padmawinata K, Pezzuto JM, Kinghorn AD.
Phenylacetic acid derivatives and a thioamide glycoside from Entada
phaseoloides. Phytochemistry 1991;30:3749–52.
[13] Sugimoto S, Matsunami K, Otsuka H. Medicinal plants of Thailand. I:
structures of rheedeiosides A–D and cis-entadamide Aβ-D-glucopyranoside
from the seed kernels of Entada rheedei. Chem Pharm Bull 2011;59:466–71.
[14] Sugimoto S, Matsunami K, Otsuka H. Medicinal plants of Thailand. II:
chemical studies on the seed kernels of Entada rheedei Sprengel. J Nat
Med 2012;66:552–7.
[15] Nzowa KL, Barboni L, Teponno RB, Ricciutelli M, Lupidi G, Quassinti L,
et al. Rheediinosides A and B, two antoproliferative and antioxidant
triterpene saponins from Entada rheedii. Phytochemistry 2010;71:
254–61.
[16] Boasso A, Royle CM, Doumazos S, Aquino VN, Biasin M, Piacentini L, et al.
Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell
responses: amodel forHIV immunopathogenesis. Blood2011;118:5152–62.
[17] Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the
mammalian brain: when physiology meets pathology. Nat Rev Neurosci
2012;13:465–77.
[18] Boasso A, Herbeuval JP, Hardy AW, Anderson SA, DolanMJ, FuchD, et al. HIV
inhibits CD4+T-cell proliferation by inducing indoleamine 2,3-dioxygenase
in plasmacytoid dendritic cells. Blood 2007;109:3351–9.
[19] Elbandy M, Miyamoto T, Delaude C, Lacaille-Dubois M-A. Acylated
preatroxigenin glycosides from Atroxima congolana. J Nat Prod 2003;66:
1154–8.
[20] Roos JW, Maughan MF, Liao Z, Hildreth JE, Clements JE. LuSIV cells: a
reporter cell line for the detection and quantitation of a single cycle of
HIV and SIV replication. Virology 2000;273:307–15.
[21] Matsumura Y, Shibata Y, Mimura T. The isolation of homogentisic
glucoside from bamboo shoot. Wakayama Igaku 1962;13:71–6.
[22] Agrawal PK. NMR spectroscopy in the structural elucidation of
oligosaccharides and glycosides. Phytochemistry 1992;31:3307–30.[23] Teponno RB, Tapondjou AL, Gatsing D, Djoukeng JD, Abou-Mansour E,
Tabacchi R, et al. Bafoudiosbulbins A, and B, two anti-salmonellal
clerodane diterpenoids from Dioscorea bulbifera L. var sativa. Phyto-
chemistry 2006;67:1957–63.
[24] Fattorusso E, Lanzotti V, Magno S, Novellino E. Trytophan derivatives
from a Mediterranean anthozoan Astroides calycularis. J Nat Prod
1985;48:924–7.
[25] Carey AF. Organic Chemistry. 6th ed. New York: McGraw-Hill; 2006.
[26] Schnabel M, Rompp B, Ruckdeschel D, Unverzagt C. Synthesis of
trytophan N-glucoside. Tetrahedron Lett 2004;45:295–7.
[27] Diem S, Bergmann J, Herderch M. Tryptophan-N-glucoside in fruits and
fruit juices. J Agr Food Chem 2000;48:4913–7.
[28] Larsen PO, Pedersen E, Sorensen H, Sorup P. Tyrosine O-glucoside and
dopamine 3-0-glucoside in seeds of Entada pursaetha. Phytochemistry
1973;12:2243–7.
[29] Carteau S, Mouscadet JF, Goulaouic H, Subra F, Auclair C. Inhibitory
effect of the polyanionic drug suramin on the in vitro HIV DNA
integration reaction. Arch Biochem Biophys 1993;305:606–10.
[30] HazudaDJ,Wolfe AL, Felock PJ, Hastings JC, Uncapher BC, SchleifWA, et al.
Inhibition of HIV-1 integrase by small molecular weight sulfonates. 3rd
Conference on Retroviruses and Opportunistic Infections, Washington
DC; 1996.
[31] Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, et al. Tryptophan
catabolism by indoleamine 2,2-dioxygenase 1 alters the balance of
TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010;2:
1–12.
[32] Davies NWS, Guillemin G, Brew BJ. Tryptophan, neurodegeneration and
HIV-associated neurocognitive disorder. Int J Trypt Res 2010;3:121–40.
[33] Zeng XW, Huang N, Xu H, Yang WB, Yang LM, Qu H, et al. Anti human
immunodeficiency virus type 1 (HIV-1) agents 4. Discovery of
5,5′-(p-phenylenebisazo)-8-hydroxyquinoline sulfonates as new HIV-1
inhibitors in vitro. Chem Pharm Bull 2010;58:976–9.
[34] Rudensey LM, Papenhausen MD, Overbaugh J. Replication and persis-
tence of simian immunodeficiency virus variants after passage in
macaque lymphocytes and established human cell lines. J Virol
1993;67:1727–33.
[35] Capece L, Lewis-Ballester A, Marti MA, Estrin DA, Yeh SR. Molecular
basis for the substrate stereoselectivity in tryptophan dioxygenase.
Biochemistry 2011;50:10910–8.
[36] Zamanakou M, Germenis AE, Karanikas V. Tumor immune escape
mediated by indoleamine 2,3-dioxygenase. Immunol Lett 2007;111:
69–75.
[37] VaccariM, Boasso A, Fenizia C, Fuchs D, Hryniewicz A,Morgan T, et al. Fatal
pancreatitis in simian immunodeficiency virus SIV(mac251)-infected
macaques treated with 2′,3′-dideoxyinosine and stavudine follow-
ing cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine
2,3-dioxygenase blockade. J Virol 2012;86:108–13.
